Pfizer's COVID-19 Vaccine Sales Decline Amid New Federal Guidance
Pfizer is experiencing a 25% drop in sales of its COVID-19 vaccine, Comirnaty, as new federal guidance restricts recommendations for its use. This decline raises concerns about vaccination rates during the fall season and reflects the ongoing challenges in managing the pandemic and adapting to changing public health policies.
Pfizer's COVID-19 Vaccine Sales Decline Amid New Federal Guidance
Pfizer is experiencing a 25% drop in sales of its COVID-19 vaccine, Comirnaty, as new federal guidance restricts recommendations for its use. This decline raises concerns about vaccination rates during the fall season and reflects the ongoing challenges in managing the pandemic and adapting to changing public health policies.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 7,702 articles worldwide
~320 per hour
654 trending stories shaping headlines
From breaking news to viral moments
Monitoring 362 trusted sources
Major outlets & specialized publications
Latest update 3 days ago
Always fresh
Latest Apps and Tools
Discover what founders, creators, and innovators are building next